Previous studies have shown that treatment with JQ1 induces neuroblastoma cell differentiation in BE(2)-C cells, demonstrated by morphologic changes including a polarized phenotype with longer neurites, as well as increased protein expression of neural differentiation markers ZNF423 and NF-M [5]. Here, ZNF423 is linked to neuroblastoma.